Lung Cancer

Concurrent administration of chemoradiation and immunotherapy did not improve survival for patients with limited-stage small cell lung cancer, according to a study presented at American Society for Radiation Oncology Annual Meeting.

The FDA approved tumor treating fields for use as part of combination treatment for certain patients with metastatic non-small cell lung cancer.

The addition of lurbinectedin to atezolizumab improved survival for certain adults with lung cancer, according to the agent’s manufacturer.

Stage at diagnosis and survival among younger individuals with cancer varied considerably by race, according to a retrospective cohort study.

BOSTON — Completing a CT scan and ordering lung cancer screening occurred more frequently if eligible patients received a digital health program intervention vs. enhanced usual care, according to data presented at the CHEST Annual Meeting.

Inpatient management of people with cancer varied considerably based on their housing status, according to results of a cross-sectional study.

The FDA has granted 510(k) clearance to qCT LN Quant, an AI solution that aids clinicians in finding lung nodule diameters, malignancy risk and management approaches, according to a manufacturer-issued press release.

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2024 World Conference on Lung Cancer, as well as Healio’s top headlines from the meeting.

The FDA approved osimertinib for treatment of certain patients with locally advanced or unresectable non-small cell lung cancer.

Older cancer survivors exhibited increased risk for cardiovascular disease than cancer-free individuals of the same age, according to a secondary analysis of a randomized study.